World Trade Center Health Program Scientific/Technical Advisory Committee; Nominations of Candidates, 40152-40153 [2013-16015]
Download as PDF
<![CDATA[
40152
Federal Register / Vol. 78, No. 128 / Wednesday, July 3, 2013 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2013–15895 Filed 7–2–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
emcdonald on DSK67QTVN1PROD with NOTICES
World Trade Center Health Program
Scientific/Technical Advisory
Committee; Nominations of
Candidates
This notice supersedes the following
documents published in the Federal
Register: June 11, 2013 Volume 78,
Number 112, Pages 35036–35037; June
21, 2013 Volume 78, Number 120, Page
37542; June 28, 2013 Volume 78,
Number 125, Page 38983.
Request for Nominations of
Candidates to Serve on the World Trade
Center Health Program Scientific/
Technical Advisory Committee (the
STAC or the Committee), Centers for
Disease Control and Prevention (CDC),
Department of Health and Human
Services.
The CDC is soliciting nominations for
membership on the World Trade Center
(WTC) Health Program Scientific/
Technical Advisory Committee (STAC).
Title I of the James Zadroga 9/11 Health
and Compensation Act of 2010 (Pub. L.
111–347) was enacted on January 2,
2011, amending the Public Health
Service Act (PHS Act) by adding Title
XXXIII establishing the WTC Health
Program within HHS (Title XXXIII of
the PHS Act is codified at 42 U.S.C.
300mm to 300mm–61). Section 3302(a)
of the PHS Act established the WTC
Health Program Scientific/Technical
Advisory Committee (STAC). The STAC
is governed by the provisions of the
Federal Advisory Committee Act, as
amended (Pub. L. 92–463, 5 U.S.C.
App.), which sets forth standards for the
formation and use of advisory
committees in the Executive Branch.
PHS Act Section 3302(a)(1) establishes
that the STAC will: review scientific
and medical evidence and to make
recommendations to the [WTC Program]
Administrator on additional WTC
Program eligibility criteria and on
additional WTC-related health
conditions.
The committee may be consulted for
other matters as related to and outlined
in the Act at the discretion of the WTC
Program Administrator. Agency or
VerDate Mar<15>2010
17:48 Jul 02, 2013
Jkt 229001
Official to Whom the Committee
Reports Section 3302(a)(1) instructs the
committee to provide advice to the WTC
Program Administrator. In accordance
with Section 3302(a)(2) of the PHS Act,
the WTC Program Administrator will
appoint the members of the committee,
which must include at least:
• 4 occupational physicians, at least
two of whom have experience treating
WTC rescue and recovery workers;
• 1 physician with expertise in
pulmonary medicine;
• 2 environmental medicine or
environmental health specialists;
• 2 representatives of WTC
responders;
• 2 representatives of certifiedeligible WTC survivors;
• 1 industrial hygienist;
• 1 toxicologist;
• 1 epidemiologist; and
• 1 mental health professional.
At this time the Administrator is
seeking nominations for members
fulfilling the following categories:
• occupational physician;
• physician with expertise in
pulmonary medicine;
• environmental medicine or
environmental health specialist;
• representative of WTC responders;
• representative of certified-eligible
WTC survivors;
Other members may be appointed at
the discretion of the WTC Program
Administrator.
A STAC member’s term appointment
may last 3 years. If a vacancy occurs, the
WTC Program Administrator may
appoint a new member who represents
the same interest as the predecessor.
STAC members may be appointed to
successive terms. The frequency of
committee meetings shall be determined
by the WTC Program Administrator
based on program needs. Meetings may
occur up to four times a year. Members
are paid the Special Government
Employee rate of $250 per day, and
travel costs and per diem are included
and based on the Federal Travel
Regulations.
Any interested person or organization
may self-nominate or nominate one or
more qualified persons for membership.
Nominations must include the
following information:
• The nominee’s contact information
and current occupation or position;
• The nominee’s resume or
curriculum vitae, including prior or
current membership on other National
Institute for Occupational Safety and
Health (NIOSH), CDC, or HHS advisory
committees or other relevant
organizations, associations, and
committees;
• The category of membership
(occupational, pulmonary or
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
environmental medicine physician,
environmental health specialist,
representative of responder or survivor
beneficiaries) that the candidate is
qualified to represent;
• A summary of the background,
experience, and qualifications that
demonstrates the nominee’s suitability
for the nominated membership category;
• Articles or other documents the
nominee has authored that indicate the
nominee’s knowledge and experience in
relevant subject categories; and
• A statement that the nominee is
aware of the nomination, is willing to
regularly attend and participate in
STAC meetings, and has no known
conflicts of interest that would preclude
membership on the Committee.
STAC members will be selected upon
the basis of their relevant experience
and competence in their respective
categorical fields. The information
received through this nomination
process, in addition to other relevant
sources of information, will assist the
WTC Program Administrator in
appointing members to serve on the
STAC. In selecting members, the WTC
Program Administrator will consider
individuals nominated in response to
this Federal Register notice as well as
other qualified individuals.
The CDC is committed to bringing
greater diversity of thought, perspective
and experience to its advisory
committees. Nominees from all races,
genders, ages, and persons living with
disabilities are encouraged to apply.
Nominees must be U.S. citizens.
Candidates invited to serve will be
asked to submit the ‘‘Confidential
Financial Disclosure Report,’’ OGE
Form 450. This form is used by CDC to
determine whether there is a financial
conflict between that person’s private
interests and activities and their public
responsibilities as a Special Government
Employee as well as any appearance of
a loss of impartiality, as defined by
Federal regulation. The form may be
viewed and downloaded at https://
www.oge.gov/Forms-Library/OGE-Form450-Confidential-Financial-DisclosureReport/. This form should not be
submitted as part of a nomination.
DATES: Nominations must be submitted
(postmarked or electronically received)
by August 9, 2013.
Submissions must be electronic or by
mail. Submissions should reference
docket #229–A. Electronic submissions:
You may electronically submit
nominations, including attachments, to
nioshdocket@cdc.gov. Attachments in
Microsoft Word are preferred. Regular,
Express, or Overnight Mail: Written
nominations may be submitted (one
E:\FR\FM\03JYN1.SGM
03JYN1
Federal Register / Vol. 78, No. 128 / Wednesday, July 3, 2013 / Notices
original and two copies) to the following
address only: NIOSH Docket 229–A c/o
Zaida Burgos, Committee Management
Specialist, National Institute for
Occupational Safety and Health, Center
for Disease Control and Prevention,
1600 Clifton Road NE., M/S E–20,
Atlanta, Georgia 30333. Telephone and
facsimile submissions cannot be
accepted. For further information
contact: Paul Middendorf, Senior Health
Scientist, 1600 Clifton Rd. NE., MS: E–
20, Atlanta, GA 30239; telephone
(404)498–2500 (this is not a toll-free
number); email pmiddendorf@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elizabeth Millington,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2013–16015 Filed 7–2–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–N–0593]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Eye Tracking
Experimental Studies To Explore
Consumer Use of Food Labeling
Information and Consumer Response
to Online Surveys
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA or we) is
announcing that a proposed collection
of information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by August 2,
2013.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or emailed to
emcdonald on DSK67QTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
17:48 Jul 02, 2013
Jkt 229001
oira_submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–New and
title ‘‘Eye Tracking Experimental
Studies to Explore Consumer Use of
Food Labeling Information and
Consumer Response to Online Surveys.’’
Also include the FDA docket number
found in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT:
Domini Bean, Office of Information
Management, Food and Drug
Administration, 1350 Piccard Dr., PI50–
400T, Rockville, MD 20850,
domini.bean@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
Eye Tracking Experimental Studies To
Explore Consumer Use of Food Labeling
Information and Consumer Response to
Online Surveys—(OMB Control
Number 0910–NEW)
I. Background
Eye tracking is a consumer research
technique often used to determine
where a person is looking while
interacting with a visual display, such
as a product package and elements of
information on the package. The
technique collects eye movement data,
i.e., fixations and saccades (jumps of the
eye), which may be superimposed on
the display image to reveal: (1) Which
parts of the display captured the
viewer’s attention, (2) the order and
path in which visual elements were
seen, and (3) the length of time they
were viewed. These data provide
detailed information on what
individuals pay attention to on product
packages, how long they spend looking
at different package elements, and how
visual attention may be related to their
reaction to the images (Refs. 1 to 4, 7).
Data from eye tracking studies can also
help improve questionnaire design.
Different respondents may pay differing
degrees of attention to the elements of
a survey question or response options.
Eye tracking data can help to identify
the need and strategies for improving
the design (Refs. 5 and 6). Finally, eye
tracking data can provide information
on the decision strategies that
individuals use under different levels of
time pressure, which can help reveal the
influence of time on busy individuals’
food choices (Refs. 4 and 7).
As a public health agency, FDA helps
consumers make informed dietary
decisions by regulating nutrition
information on food labels, among other
activities. An understanding of how
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
40153
visual elements (e.g., labeling
statements such as claims, disclosure
statements, logos, and Nutrition Facts
label) influence consumers’ perceptions
and choices of products can assist us in
developing labeling information to help
consumers make informed dietary
decisions. In addition, we use selfadministered questionnaires in online
experimental studies to assess consumer
reactions to nutrition information on
food packages. An understanding of
how respondents react to survey
materials that are presented visually
will enhance our ability in collecting
better consumer data to help us fulfill
our missions.
The proposed data collection will use
eye tracking research to examine
consumers’ eye movements to achieve
three goals: (1) To better understand
consumer reaction to specific food
labeling information, (2) to better
understand survey respondent reaction
to specific survey questions related to
nutrition and health, and (3) to better
understand how time pressure
influences the priority and quality of
decision making and survey response.
In order to observe consumers’ eye
movement in different types of settings,
we propose to conduct two separate
studies, one in each of two different
settings. Study 1 is a laboratory study
that will ask participants to view on a
computer screen mockups of food labels
and perform tasks as well as answer
other survey questions. Study 2 is an instore study that will record eye
movement data from grocery shoppers
while they shop for preselected product
categories. The studies will use two
different survey instruments. Study
participants will come from two
separate convenience samples.
A. Study 1 (Laboratory Study)
Study 1 is a controlled randomized
experiment. It has two objectives. The
first objective is to collect data on how
consumers view and process label
information. The data will be used to
test the hypothesis that one or more
label and information characteristics
will cause variations in viewing and
processing. In this proposed study, we
will focus specifically on the following
characteristics: (1) Presence and type of
nutrition symbols, together with
presence of claims, on the Principal
Display Panel (PDP) of a conventional
food; (2) presence of a disclosure
statement (21 CFR 101.13(h)(1)–(3)) on
the PDP of a conventional food that
makes a nutrient content claim; (3)
format of the Nutrition Facts label on a
conventional food product; (4) presence
of a Dietary Supplement Health and
Education Act disclaimer on the PDP of
E:\FR\FM\03JYN1.SGM
03JYN1
]]>Agencies
[Federal Register Volume 78, Number 128 (Wednesday, July 3, 2013)]
[Notices]
[Pages 40152-40153]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-16015]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
World Trade Center Health Program Scientific/Technical Advisory
Committee; Nominations of Candidates
This notice supersedes the following documents published in the
Federal Register: June 11, 2013 Volume 78, Number 112, Pages 35036-
35037; June 21, 2013 Volume 78, Number 120, Page 37542; June 28, 2013
Volume 78, Number 125, Page 38983.
Request for Nominations of Candidates to Serve on the World Trade
Center Health Program Scientific/Technical Advisory Committee (the STAC
or the Committee), Centers for Disease Control and Prevention (CDC),
Department of Health and Human Services.
The CDC is soliciting nominations for membership on the World Trade
Center (WTC) Health Program Scientific/Technical Advisory Committee
(STAC). Title I of the James Zadroga 9/11 Health and Compensation Act
of 2010 (Pub. L. 111-347) was enacted on January 2, 2011, amending the
Public Health Service Act (PHS Act) by adding Title XXXIII establishing
the WTC Health Program within HHS (Title XXXIII of the PHS Act is
codified at 42 U.S.C. 300mm to 300mm-61). Section 3302(a) of the PHS
Act established the WTC Health Program Scientific/Technical Advisory
Committee (STAC). The STAC is governed by the provisions of the Federal
Advisory Committee Act, as amended (Pub. L. 92-463, 5 U.S.C. App.),
which sets forth standards for the formation and use of advisory
committees in the Executive Branch. PHS Act Section 3302(a)(1)
establishes that the STAC will: review scientific and medical evidence
and to make recommendations to the [WTC Program] Administrator on
additional WTC Program eligibility criteria and on additional WTC-
related health conditions.
The committee may be consulted for other matters as related to and
outlined in the Act at the discretion of the WTC Program Administrator.
Agency or Official to Whom the Committee Reports Section 3302(a)(1)
instructs the committee to provide advice to the WTC Program
Administrator. In accordance with Section 3302(a)(2) of the PHS Act,
the WTC Program Administrator will appoint the members of the
committee, which must include at least:
4 occupational physicians, at least two of whom have
experience treating WTC rescue and recovery workers;
1 physician with expertise in pulmonary medicine;
2 environmental medicine or environmental health
specialists;
2 representatives of WTC responders;
2 representatives of certified-eligible WTC survivors;
1 industrial hygienist;
1 toxicologist;
1 epidemiologist; and
1 mental health professional.
At this time the Administrator is seeking nominations for members
fulfilling the following categories:
occupational physician;
physician with expertise in pulmonary medicine;
environmental medicine or environmental health specialist;
representative of WTC responders;
representative of certified-eligible WTC survivors;
Other members may be appointed at the discretion of the WTC Program
Administrator.
A STAC member's term appointment may last 3 years. If a vacancy
occurs, the WTC Program Administrator may appoint a new member who
represents the same interest as the predecessor. STAC members may be
appointed to successive terms. The frequency of committee meetings
shall be determined by the WTC Program Administrator based on program
needs. Meetings may occur up to four times a year. Members are paid the
Special Government Employee rate of $250 per day, and travel costs and
per diem are included and based on the Federal Travel Regulations.
Any interested person or organization may self-nominate or nominate
one or more qualified persons for membership.
Nominations must include the following information:
The nominee's contact information and current occupation
or position;
The nominee's resume or curriculum vitae, including prior
or current membership on other National Institute for Occupational
Safety and Health (NIOSH), CDC, or HHS advisory committees or other
relevant organizations, associations, and committees;
The category of membership (occupational, pulmonary or
environmental medicine physician, environmental health specialist,
representative of responder or survivor beneficiaries) that the
candidate is qualified to represent;
A summary of the background, experience, and
qualifications that demonstrates the nominee's suitability for the
nominated membership category;
Articles or other documents the nominee has authored that
indicate the nominee's knowledge and experience in relevant subject
categories; and
A statement that the nominee is aware of the nomination,
is willing to regularly attend and participate in STAC meetings, and
has no known conflicts of interest that would preclude membership on
the Committee.
STAC members will be selected upon the basis of their relevant
experience and competence in their respective categorical fields. The
information received through this nomination process, in addition to
other relevant sources of information, will assist the WTC Program
Administrator in appointing members to serve on the STAC. In selecting
members, the WTC Program Administrator will consider individuals
nominated in response to this Federal Register notice as well as other
qualified individuals.
The CDC is committed to bringing greater diversity of thought,
perspective and experience to its advisory committees. Nominees from
all races, genders, ages, and persons living with disabilities are
encouraged to apply. Nominees must be U.S. citizens.
Candidates invited to serve will be asked to submit the
``Confidential Financial Disclosure Report,'' OGE Form 450. This form
is used by CDC to determine whether there is a financial conflict
between that person's private interests and activities and their public
responsibilities as a Special Government Employee as well as any
appearance of a loss of impartiality, as defined by Federal regulation.
The form may be viewed and downloaded at https://www.oge.gov/Forms-Library/OGE-Form-450-Confidential-Financial-Disclosure-Report/. This
form should not be submitted as part of a nomination.
DATES: Nominations must be submitted (postmarked or electronically
received) by August 9, 2013.
Submissions must be electronic or by mail. Submissions should
reference docket 229-A. Electronic submissions: You may
electronically submit nominations, including attachments, to
nioshdocket@cdc.gov. Attachments in Microsoft Word are preferred.
Regular, Express, or Overnight Mail: Written nominations may be
submitted (one
[[Page 40153]]
original and two copies) to the following address only: NIOSH Docket
229-A c/o Zaida Burgos, Committee Management Specialist, National
Institute for Occupational Safety and Health, Center for Disease
Control and Prevention, 1600 Clifton Road NE., M/S E-20, Atlanta,
Georgia 30333. Telephone and facsimile submissions cannot be accepted.
For further information contact: Paul Middendorf, Senior Health
Scientist, 1600 Clifton Rd. NE., MS: E-20, Atlanta, GA 30239; telephone
(404)498-2500 (this is not a toll-free number); email
pmiddendorf@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both the Centers for Disease Control and Prevention and the Agency for
Toxic Substances and Disease Registry.
Elizabeth Millington,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2013-16015 Filed 7-2-13; 8:45 am]
BILLING CODE 4163-18-P
